Previous GWAS screening has shown that SPOP is mutated in several human cancers, including prostate cancer and gastric cancer.21, 22 Interestingly, most SPOP mutations localize in the MATH domain, which presumably impair its ability to bind substrates. This evidence concerns the gene SPOP and prostate carcinoma.